These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Drastic decrease of transcription activity due to hypermutated long terminal repeat (LTR) region in different HIV-1 subtypes and recombinants. de Arellano ER; Alcamí J; López M; Soriano V; Holguín A Antiviral Res; 2010 Nov; 88(2):152-9. PubMed ID: 20713090 [TBL] [Abstract][Full Text] [Related]
3. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication. McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770 [TBL] [Abstract][Full Text] [Related]
4. The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter. Gómez-Gonzalo M; Carretero M; Rullas J; Lara-Pezzi E; Aramburu J; Berkhout B; Alcamí J; López-Cabrera M J Biol Chem; 2001 Sep; 276(38):35435-43. PubMed ID: 11457829 [TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1. Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279 [TBL] [Abstract][Full Text] [Related]
6. NF-κB-Interacting Long Noncoding RNA Regulates HIV-1 Replication and Latency by Repressing NF-κB Signaling. Wang H; Liu Y; Huan C; Yang J; Li Z; Zheng B; Wang Y; Zhang W J Virol; 2020 Aug; 94(17):. PubMed ID: 32581100 [TBL] [Abstract][Full Text] [Related]
7. A Stronger Transcription Regulatory Circuit of HIV-1C Drives the Rapid Establishment of Latency with Implications for the Direct Involvement of Tat. Chakraborty S; Kabi M; Ranga U J Virol; 2020 Sep; 94(19):. PubMed ID: 32669338 [TBL] [Abstract][Full Text] [Related]
8. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication. Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193 [TBL] [Abstract][Full Text] [Related]
9. Sustained induction of NF-kappa B is required for efficient expression of latent human immunodeficiency virus type 1. Williams SA; Kwon H; Chen LF; Greene WC J Virol; 2007 Jun; 81(11):6043-56. PubMed ID: 17376917 [TBL] [Abstract][Full Text] [Related]
10. HIV-1 transcriptional silencing caused by TRIM22 inhibition of Sp1 binding to the viral promoter. Turrini F; Marelli S; Kajaste-Rudnitski A; Lusic M; Van Lint C; Das AT; Harwig A; Berkhout B; Vicenzi E Retrovirology; 2015 Dec; 12():104. PubMed ID: 26683615 [TBL] [Abstract][Full Text] [Related]
11. The NF-kappa B and Sp1 motifs of the human immunodeficiency virus type 1 long terminal repeat function as novel thyroid hormone response elements. Desai-Yajnik V; Samuels HH Mol Cell Biol; 1993 Aug; 13(8):5057-69. PubMed ID: 8393143 [TBL] [Abstract][Full Text] [Related]
12. Transcriptional activation of the integrated chromatin-associated human immunodeficiency virus type 1 promoter. El Kharroubi A; Piras G; Zensen R; Martin MA Mol Cell Biol; 1998 May; 18(5):2535-44. PubMed ID: 9566873 [TBL] [Abstract][Full Text] [Related]
13. Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1. Majello B; De Luca P; Hagen G; Suske G; Lania L Nucleic Acids Res; 1994 Nov; 22(23):4914-21. PubMed ID: 7800480 [TBL] [Abstract][Full Text] [Related]
14. Functional Incompatibility between the Generic NF-κB Motif and a Subtype-Specific Sp1III Element Drives the Formation of the HIV-1 Subtype C Viral Promoter. Verma A; Rajagopalan P; Lotke R; Varghese R; Selvam D; Kundu TK; Ranga U J Virol; 2016 Aug; 90(16):7046-7065. PubMed ID: 27194770 [TBL] [Abstract][Full Text] [Related]
15. Human immunodeficiency virus type 1 genome activation induced by human T-cell leukemia virus type 1 Tax protein is through cooperation of NF-kappaB and Tat. Cheng H; Tarnok J; Parks WP J Virol; 1998 Aug; 72(8):6911-6. PubMed ID: 9658145 [TBL] [Abstract][Full Text] [Related]
16. Cellular RelB interacts with the transactivator Tat and enhance HIV-1 expression. Wang M; Yang W; Chen Y; Wang J; Tan J; Qiao W Retrovirology; 2018 Sep; 15(1):65. PubMed ID: 30241541 [TBL] [Abstract][Full Text] [Related]
17. Second-site long terminal repeat (LTR) revertants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription factors TFIID and TFIIA. Kashanchi F; Shibata R; Ross EK; Brady JN; Martin MA J Virol; 1994 May; 68(5):3298-307. PubMed ID: 8151790 [TBL] [Abstract][Full Text] [Related]
18. An emerging and variant viral promoter of HIV-1 subtype C exhibits low-level gene expression noise. Ali H; Bhange D; Mehta K; Gohil Y; Prajapati HK; Byrareddy SN; Buch S; Ranga U Retrovirology; 2021 Sep; 18(1):27. PubMed ID: 34538278 [TBL] [Abstract][Full Text] [Related]
19. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells. Chang LJ; Zhang C Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208 [TBL] [Abstract][Full Text] [Related]
20. Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein. Kamine J; Subramanian T; Chinnadurai G Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8510-4. PubMed ID: 1924310 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]